Alector, Inc. Profile Avatar - Palmy Investing

Alector, Inc.

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment…

Biotechnology
US, South San Francisco [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of ALEC's Analysis
CIK: 1653087 CUSIP: 014442107 ISIN: US0144421072 LEI: - UEI: -
Secondary Listings
ALEC has no secondary listings inside our databases.